Considerations before the decision-making including fluvoxamine as a treatment option in guidelines on the management of COVID-19

doi:10.1017/S0033291722000022

UM > Faculty of Health Sciences

Residential College	false
Status	已發表Published
	Considerations before the decision-making including fluvoxamine as a treatment option in guidelines on the management of COVID-19
	Zhao, Yan Jie 1,2,3; Jin, Yu 4; Zhang, Qinge 5; Su, Zhaohui 6; Cheung, Teris 7; Zheng, Wei 8; Ng, Chee H.9; Xiang, Yu Tao1,2,3
	2023-07-16
Source Publication	Psychological Medicine
ISSN	0033-2917
Volume	53 Issue:9 Pages:4296-4297
DOI	10.1017/S0033291722000022
URL	View the original
Language	英語English
Scopus ID	2-s2.0-85125199682
Fulltext Access	View Full-Text via DOI View Full-Text via Web of Science View Full-Text via Scopus
Citation statistics
Document Type	Journal article
Collection	Faculty of Health Sciences DEPARTMENT OF PUBLIC HEALTH AND MEDICINAL ADMINISTRATION
Corresponding Author	Xiang, Yu Tao
Affiliation	1.Unit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao, Macao 2.Centre for Cognitive and Brain Sciences, University of Macau, Macao, Macao 3.Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao SAR, Macao 4.College of Education for the Future, Beijing Normal University, Beijing, China 5.The National Clinical Research Center for Mental Disorders, Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, The Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China 6.Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, United States 7.School of Nursing, Hong Kong Polytechnic University, Hong Kong, Hong Kong 8.The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, China 9.Department of Psychiatry, The Melbourne Clinic, St Vincent's Hospital, University of Melbourne, Richmond, Australia
First Author Affilication	Faculty of Health Sciences; University of Macau
Corresponding Author Affilication	Faculty of Health Sciences; University of Macau
Recommended Citation GB/T 7714	Zhao, Yan Jie,Jin, Yu,Zhang, Qinge,et al. Considerations before the decision-making including fluvoxamine as a treatment option in guidelines on the management of COVID-19[J]. Psychological Medicine, 2023, 53(9), 4296-4297.
APA	Zhao, Yan Jie., Jin, Yu., Zhang, Qinge., Su, Zhaohui., Cheung, Teris., Zheng, Wei., Ng, Chee H.., & Xiang, Yu Tao (2023). Considerations before the decision-making including fluvoxamine as a treatment option in guidelines on the management of COVID-19. Psychological Medicine, 53(9), 4296-4297.
MLA	Zhao, Yan Jie,et al."Considerations before the decision-making including fluvoxamine as a treatment option in guidelines on the management of COVID-19".Psychological Medicine 53.9(2023):4296-4297.

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh